HOME Top Market Reports Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

Continuous Renal Replacement Therapy (CRRT) Market by Product (Systems, Disposables (Hemofilters & Bloodlines), & Dialysate), Modality (SCUF, CVVH, CVVHD, CVVHDF), Adoption & Procedures, and Region (Europe, North America, Asia-Pacific) - Forecast to 2022

By: marketsandmarkets.com
Publishing Date: July 2017
Report Code: MD 3842

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global CRRT market is expected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%.

Objectives of the study:

  • To define, describe, and forecast the continuous renal replacement therapy (CRRT) market on the basis of products and modalities
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze the market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the market size (by value) in North America (U.S. and Canada), Europe (Germany, France, U.K., and the Rest of Europe), Asia-Pacific (China, India, Japan, and the Rest of Asia-Pacific), and the Rest of the World
  • To profile key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers and acquisitions; and research and development activities in the CRRT market

Both, top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall CRRT market. The research study involved extensive use of secondary sources; such as, Bloomberg Business, Factiva, government databases, USRDS, International Society of Nephrology, International Federation of Kidney Foundations, The Intensive Care Society, The European Renal Association, The Asian Pacific Society of Nephrology, and MarketsandMarkets Analysis. In-depth interviews were conducted to obtain and verify critical qualitative and quantitative information as well as assess prospects.

Continuous Renal Replacement Therapy (CRRT) Market

To know about the assumptions considered for the study, download the pdf brochure

As of 2016, Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), and B. Braun Melsungen AG (Germany) holds the leading position in the market. These companies adopted product launches, agreements, and partnerships as their business strategies to ensure their market position. Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan) are some of the other major players in this market.

Target Audience

  • CRRT manufacturers, suppliers, and distributors
  • CRRT service providers
  • Renal research laboratories
  • Renal associations and organizations
  • Hospitals and critical care units
  • Academic medical centers and universities
  • Business research and consulting service providers

Scope of the Report

This research report categorizes the CRRT market into the following segments:

Global CRRT Market, by Product

  • Dialysate and Replacement Fluids
  • Disposables
  • Bloodline Sets
  • Hemofilters
  • Other Disposables
  • Systems

Global CRRT Market, by Modality

  • Slow continuous ultrafiltration (SCUF)
  • Continuous venovenous hemofiltration (CVVH)
  • Continuous venovenous hemodialysis (CVVHD)
  • Continuous venovenous hemodiafiltration (CVVHDF)

Global CRRT Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific CRRT market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Latin American CRRT market into Brazil, Argentina, and the Rest of Latin America

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Approach
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 33)

4 Premium Insights (Page No. - 36)
    4.1 CRRT: Market Overview (2017)
    4.2 Global CRRT Market, By Product, 2017 vs 2022
    4.3 CRRT Market, By Modality and Region (2017)
    4.4 Geographic Snapshot: CRRT Market (2017)

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Global Incidence of AKI
                    5.2.1.2 Growing Number of ICU Patients
                    5.2.1.3 Clinical Advantages of CRRT Over Intermittent Blood Purification Techniques
                    5.2.1.4 Technological Advancements and New Product Launches
                    5.2.1.5 Increasing Incidence of Sepsis
                    5.2.1.6 Growing Prevalence of Diabetes and Hypertension
           5.2.2 Restraints
                    5.2.2.1 High Procedural Cost of CRRT
                    5.2.2.2 Stringent Regulatory Guidelines for CRRT in North America
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Increasing Applications of CRRT
                               5.2.3.2.1 Evolution of CRRT From A Simple Renal Replacement Treatment to A Multi-Organ Support Therapy (MOST)
                               5.2.3.2.2 Progression of CRRT From Adaptive Renal Devices to Multipurpose Treatment Machines
                    5.2.3.3 Ongoing Research to Establish the Safety and Efficacy Profile of CRRT
                    5.2.3.4 Development of A CRRT System for Pediatric Patients
                               5.2.3.4.1 The Carpediem Project
                    5.2.3.5 Untapped Market Growth Opportunities in North America
           5.2.4 Challenges
                    5.2.4.1 High Complexity of the Therapy
                               5.2.4.1.1 Lack of Standard Treatment Guidelines in Developing Countries
                               5.2.4.1.2 Complications Associated With CRRT
                    5.2.4.2 Shortage of Trained ICU Nurses in Developed Countries
                    5.2.4.3 Poor Reimbursement Scenario in Developing Countries
                    5.2.4.4 Lack of Awareness About the Benefits of CRRT

6 Industry Insights (Page No. - 51)
    6.1 Introduction
    6.2 Reimbursement Scenario
           6.2.1 North America
           6.2.2 Europe
           6.2.3 Asia-Pacific (Excluding Japan)
           6.2.4 Japan
           6.2.5 Rest of the World
    6.3 Regulatory Landscape
           6.3.1 North America
           6.3.2 Europe
           6.3.3 Asia-Pacific
           6.3.4 Rest of the World
           6.3.5 Industry Trends
                    6.3.5.1 Training Programs for the Operation of CRRT Devices
                    6.3.5.2 Rising Adoption of User-Friendly CRRT Machines
                    6.3.5.3 Development of A CRRT System for Pediatric Patients
    6.4 Porter’s Five Forces Analysis
           6.4.1 Competitive Intensity
           6.4.2 Bargaining Power of Buyers
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Threat of Substitutes
           6.4.5 Threat of New Entrants
    6.5 Pricing and Cost Analysis
    6.6 Strategic Recommendations
           6.6.1 Design Recommendations
           6.6.2 Key Strategies for Players Seeking to Enter the CRRT Market

7 Adoption of Continuous Renal Replacement Therapy, By Region (Page No. - 65)
    7.1 Introduction
    7.2 Utilization of CRRT Procedures, By Region
    7.3 Number of CRRT Patients, By Region

8 Continuous Renal Replacement Therapy Market, By Product (Page No. - 69)
    8.1 Introduction
           8.1.1 Dialysates and Replacement Fluids
           8.1.2 Disposables
                    8.1.2.1 Hemofilters
                    8.1.2.2 Bloodline Sets (Tubing Sets)
                    8.1.2.3 Other Disposables
           8.1.3 Systems

9 Continuous Renal Replacement Therapy Market, By Modality (Page No. - 80)
    9.1 Introduction
    9.2 Continuous Venovenous Hemofiltration (CVVH)
    9.3 Continuous Venovenous Hemodiafiltration (CVVHDF)
    9.4 Continuous Venovenous Hemodialysis (CVVHD)
    9.5 Slow Continuous Ultrafiltration (SCUF)

10 Continuous Renal Replacement Therapy Market, By Region (Page No. - 92)
     10.1 Introduction
     10.2 Europe
             10.2.1 Approval of CRRT Machines for Multiple Applications
             10.2.2 Intensivist Preference for CRRT for AKI Treatment
             10.2.3 Players Focus on Leveraging Growth Opportunities in Europe
             10.2.4 Germany
                        10.2.4.1 Rising Focus of Players on the German CRRT Market
                        10.2.4.2 Favorable Reimbursement for CRRT
             10.2.5 U.K.
                        10.2.5.1 Rising Awareness About AKI in the U.K.
             10.2.6 France
                        10.2.6.1 Significant Number of Ongoing Clinical Studies
             10.2.7 Rest of Europe
     10.3 North America
             10.3.1 High Preference for Other Dialysis Modalities
             10.3.2 Regulatory Policies, A Key Hindrance to Market Growth
             10.3.3 U.S.
                        10.3.3.1 Growth in AKI Prevalence
                        10.3.3.2 New Product Development to Boost the Demand for CRRT Products
                        10.3.3.3 Ongoing Clinical Trials to Prove the Safety and Efficacy of CRRT Products
                        10.3.3.4 Shortage of Registered Nurses in ICU Settings
             10.3.4 Canada
                        10.3.4.1 Rising AKI Prevalence
                        10.3.4.2 High Cost of CRRT as Compared to Ihd
     10.4 Asia-Pacific
             10.4.1 Increasing Number of Sepsis Cases in India
             10.4.2 Studies and Clinical Trials to Establish the Safety and Efficacy Profile of CRRT
             10.4.3 Unfavorable Reimbursement Scenario
             10.4.4 Japan
                        10.4.4.1 Increasing Use of CRRT for Non-Renal Indications
                        10.4.4.2 Well-Established Healthcare System
                        10.4.4.3 Large Number of Domestic Manufacturers—A Barrier to the Entry of Major Players
             10.4.5 China
                        10.4.5.1 Rising Incidence of AKI and Esrd in China
                        10.4.5.2 Ongoing Research Studies
             10.4.6 India
                        10.4.6.1 Rising Sepsis Cases in India
                        10.4.6.2 Increase in the Number of Dialysis Patients
                        10.4.6.3 Rising Number of Patients Admitted to ICUs
                        10.4.6.4 Unfavorable Reimbursement Scenario
                        10.4.6.5 Lack of Randomized Trials and Dearth of Technical Expertise
                        10.4.6.6 Dearth of Indigenous Manufacturers for CRRT Products in India
             10.4.7 Rest of Asia-Pacific
                        10.4.7.1 Taiwan, A Lucrative Market for CRRT Players
     10.5 Rest of the World (RoW)
             10.5.1 Latin America and the Middle East
             10.5.2 New Amendments Open Brazilian Healthcare Industry to Foreign Investment

11 Competitive Landscape (Page No. - 126)
     11.1 Introduction
             11.1.1 Visionary Leaders
             11.1.2 Innovators
             11.1.3 Dynamic Differentiators
             11.1.4 Emerging Companies
     11.2 Strength of Product Portfolio
     11.3 Business Strategy Excellence
     11.4 Competitive Intensity
             11.4.1 Evaluation Parameters and Scores
             11.4.2 Scoring Methodology
             11.4.3 Competitive Intensity Score, By Company
                        11.4.3.1 Baxter International Inc.
                        11.4.3.2 Fresenius Medical Care AG & Co. KGaA
                        11.4.3.3 Nikkiso Co., Ltd.
                        11.4.3.4 B. Braun Melsungen AG
                        11.4.3.5 Nxstage Medical, Inc.
             11.4.4 Competitive Intensity – Mapping of Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., B. Braun Melsungen AG, and Nxstage Medical, Inc.

*Top 25 Companies Analyzed for This Studies are - Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nxstage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), BeLLCo S.R.L. (Italy), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medica S.P.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma Spol. S.R.O. (Czech Republic), Medtronic PLC (Ireland), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd (China), Cytosorbents Corporation (U.S.), Biomedica Spol. S R.O. (Czech Republic), Anjue Medical Equipment Co., Ltd. (China), Jiangxi Sanxin Medtec Co., Ltd. (China), Proxima Medicare (India), Nipro Corporation (Japan), Cytopherx, Inc. (U.S.), Dialysis Solutions Inc. (U.S.), Kimal Electronics Ltd (U.K.), Bl Lifesciences (India)

12 Company Profiles (Page No. - 138)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     12.1 Baxter International Inc.
     12.2 Fresenius Medical Care AG & Co. KGaA
     12.3 Nikkiso Co., Ltd.
     12.4 Nxstage Medical, Inc.
     12.5 B. Braun Melsungen AG
     12.6 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
     12.7 BeLLCo S.R.L. (A Part of Medtronic PLC)
     12.8 Toray Medical Co., Ltd.
     12.9 Infomed SA
     12.10 Medica S.P.A.
     12.11 Medical Components, Inc.
     12.12 Medites Pharma Spol. S.R.O.
     12.13 Medtronic PLC
     12.14 SWS Hemodialysis Care Co. Ltd.
     12.15 Ningbo Tianyi Medical Appliance Co., Ltd.

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 179)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (65 Tables)

Table 1 Average Selling Price of CRRT Machines, By Manufacturer, 2016 (USD)
Table 2 Average Selling Price of CRRT Bloodlines and Dialysate Bags, 2016 (USD)
Table 3 Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 4 Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Region, 2015–2022 (USD Million)
Table 5 Europe: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 6 North America: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 7 Asia-Pacific: Continuous Renal Replacement Therapy Dialysates & Replacement Fluids Market, By Country, 2015–2022 (USD Million)
Table 8 Continuous Renal Replacement Therapy Disposables Market, By Type, 2015–2022 (USD Million)
Table 9 Continuous Renal Replacement Therapy Disposables Market, By Region, 2015–2022 (USD Million)
Table 10 Europe: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 11 North America: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 12 Asia-Pacific: Continuous Renal Replacement Therapy Disposables Market, By Country, 2015–2022 (USD Million)
Table 13 Continuous Renal Replacement Therapy Systems Market, By Region, 2015–2022 (USD Million)
Table 14 Europe: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 15 North America: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 16 Asia-Pacific: Continuous Renal Replacement Therapy Systems Market, By Country, 2015–2022 (USD Million)
Table 17 Continuous Renal Replacement Therapy Market, By Modality, 2015–2022 (USD Million)
Table 18 Market for CVVH, By Region, 2015–2022 (USD Million)
Table 19 Europe: Continuous Renal Replacement Therapy Market for CVVH, By Country, 2015–2022 (USD Million)
Table 20 North America: Therapy Market for CVVH, By Country, 2015–2022 (USD Million)
Table 21 Asia-Pacific: Market for CVVH, By Country, 2015–2022 (USD Million)
Table 22 Continuous Renal Replacement Therapy Market for CVVHDF, By Region, 2015–2022 (USD Million)
Table 23 Europe: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 24 North America: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 25 Asia-Pacific: Market for CVVHDF, By Country, 2015–2022 (USD Million)
Table 26 Market for CVVHD, By Region, 2015–2022 (USD Million)
Table 27 Europe: Continuous Renal Replacement Therapy Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 28 North America: Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 29 Asia-Pacific: Market for CVVHD, By Country, 2015–2022 (USD Million)
Table 30 Market for SCUF, By Region, 2015–2022 (USD Million)
Table 31 Europe: Market for SCUF, By Country, 2015–2022 (USD Million)
Table 32 North America: Market for SCUF, By Country, 2015–2022 (USD Million)
Table 33 Asia-Pacific: Continuous Renal Replacement Therapy Market for SCUF, By Country, 2015–2022 (USD Million)
Table 34 Market, By Region, 2015–2022 (USD Million)
Table 35 Europe: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Market, By Product, 2015–2022 (USD Million)
Table 37 Europe: Market, By Modality, 2015–2022 (USD Million)
Table 38 Germany: Continuous Renal Replacement Therapy Market, By Product, 2013-2020 (USD Million)
Table 39 Germany: Market, By Modality, 2015–2022 (USD Million)
Table 40 U.K.: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 41 U.K.: Market, By Modality, 2015–2022 (USD Million)
Table 42 France: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 43 France: Market, By Modality, 2015–2022 (USD Million)
Table 44 RoE: Continuous Renal Replacement Therapy Market Size, By Product, 2015–2022 (USD Million)
Table 45 RoE: Market Size, By Modality, 2015–2022 (USD Million)
Table 46 North America: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 47 North America: Market, By Product, 2015–2022 (USD Million)
Table 48 North America: Market, By Modality, 2015–2022 (USD Million)
Table 49 U.S.: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 50 U.S.: Market, By Modality, 2015–2022 (USD Million)
Table 51 Canada: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 52 Canada: Market, By Modality, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Continuous Renal Replacement Therapy Market, By Country, 2015–2022 (USD Million)
Table 54 Asia-Pacific: Market, By Product, 2015–2022 (USD Million)
Table 55 Asia-Pacific: Market, By Modality, 2015–2022 (USD Million)
Table 56 Japan: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 57 Japan: Market, By Modality, 2015–2022 (USD Million)
Table 58 China: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 59 China: Market, By Modality, 2015–2022 (USD Million)
Table 60 India: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 61 India: Market, By Modality, 2015–2022 (USD Million)
Table 62 RoAPAC: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 63 RoAPAC: Market, By Modality, 2015–2022 (USD Million)
Table 64 RoW: Continuous Renal Replacement Therapy Market, By Product, 2015–2022 (USD Million)
Table 65 RoW: Market, By Modality, 2015–2022 (USD Million)


List of Figures (51 Figures)

Figure 1 Global Continuous Renal Replacement Therapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Supply Side
Figure 5 Demand Side
Figure 6 Estimation of CRRT Procedural Volume
Figure 7 Research Methodology: Top-Down Approach [For Market Size Estimation of Disposables (Bloodline Sets, Hemofilters, and Other Disposables)]
Figure 8 Research Methodology: Top-Down Approach (For Market Size Estimation of CRRT Systems)
Figure 9 Research Methodology: Bottom-Up Approach
Figure 10 Data Triangulation Steps (Top-Down and Bottom-Up Approaches)
Figure 11 Data Triangulation Methodology
Figure 12 Global CRRT Market By Product, 2017 vs 2022
Figure 13 Hemofilters to Form the Largest Segment of CRRT Disposables Market in 2017
Figure 14 CVVHDF Expected to Be the Fastest-Growing Segment During 2017-2022
Figure 15 Asia-Pacific to Grow at the Highest Growth Rate in the Forecast Period
Figure 16 Rising Prevalence of AKI to Drive the Global CRRT Market During the Forecast Period
Figure 17 Dialysates & Replacement Fluids to Dominate the Global CRRT Market During the Forecast Period
Figure 18 Europe to Dominate CRRT Modality Segments in 2017
Figure 19 Europe to Dominate the Global CRRT Market During the Forecast Period
Figure 20 Continuous Renal Replacement Therapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Global Incidence of Acute Kidney Injury (AKI), 2010 vs 2015 vs 2020
Figure 22 Key Factors Affecting the Reimbursement Rates for CRRT Procedures
Figure 23 Reimbursement Scenario for CRRT (As of 2016)
Figure 24 Reimbursement Structures in Europe
Figure 25 Key Regulatory Bodies Involved in the Approval of New CRRT Products
Figure 26 Porter’s Five Forces Analysis – Global CRRT Market
Figure 27 Design Recommendations for CRRT Machines
Figure 28 Utilization of Continuous Renal Replacement Therapy and Dialysis for the Treatment of Renal Patients in ICUs, By Region (2016)
Figure 29 Rate of Switching From CRRT to IHD, By Region, 2016
Figure 30 Number of CRRT Patients Across the Globe, 2016
Figure 31 Global Continuous Renal Replacement Therapy Market, By Product (2017 vs 2022)
Figure 32 Types of CRRT Modalities
Figure 33 Global Continuous Renal Replacement Therapy Market, By Modality (2017 vs 2022)
Figure 34 Europe to Dominate the Global CRRT Market During the Forecast Period
Figure 35 Europe: CRRT Market Snapshot
Figure 36 North America: CRRT Market Snapshot
Figure 37 Asia-Pacific: CRRT Market Snapshot
Figure 38 RoW: CRRT Market Snapshot
Figure 39 Competitive Leadership Mapping
Figure 40 Global CRRT Market Share, By Key Players (2016)
Figure 41 Scoring Methodology
Figure 42 Comparison of Competitive Intensity Scores
Figure 43 Relative Positioning of Companies Based on Competitive Intensity Score and CRRT Focus
Figure 44 Baxter International Inc.: Company Snapshot (2016)
Figure 45 Fresenius Medical Care AG & Co. KGaA: Company Snapshot (2016)
Figure 46 Nikkiso Co., Ltd.: Company Snapshot (2015)
Figure 47 Nxstage Medical, Inc.: Company Snapshot (2016)
Figure 48 B. Braun Melsungen AG: Company Snapshot (2016)
Figure 49 Asahi Kasei Corporation: Company Snapshot (2015)
Figure 50 Toray Industries, Inc.: Company Snapshot (2016)
Figure 51 Medtronic PLC.: Company Snapshot (2016)

The global CRRT market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market.

This CRRT market is segmented based on product, and modality. On the basis of product, the CRRT market is segmented into CRRT systems, disposables, and dialysates & replacement fluids, in which dialysates and replacement fluids is expected to account for the largest share of the market. This is attributed to the large volume of these products required during CRRT procedures.

Based on modality, the CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). The CVVH segment is estimated to command the larger share of the global CRRT market due to the wide adoption of this modality among healthcare providers owing to its wide range of advantages (such as removal of solutes in large quantities, easy fluid balance maintenance, and superior outcomes) over other CRRT modalities.

Continuous Renal Replacement Therapy (CRRT) Market

The report covers the CRRT market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Europe is expected to command the largest share of the market in 2017. However, Asia-Pacific is expected to register the highest growth rate during the forecast period due to the large acute kidney injury patient population, high utilization of CRRT in Australia and Japan, and improving healthcare infrastructure across Asian countries.

However, high procedural cost of CRRT and stringent regulatory guidelines for CRRT in North America are the major factors restraining the growth of this market.

The major players in the market are Baxter International Inc. (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), NxStage Medical, Inc. (U.S.), Asahi Kasei Corporation (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), and Toray Medical Co., Ltd. (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo